Comparing 3 vs 6 Cycles of Platinum-based Chemotherapy Prior to Maintenance Avelumab in Advanced Urothelial Cancer

Clinical trial NCT06892860 · RECRUITING

Trial details

NCT number: NCT06892860
Sponsor: Queen Mary University of London
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Urinary Bladder Neoplasms

Start date: 2021-12-16
Primary completion: 2027-06-30
Enrollment: 320

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.